Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

HealthLynked (HLYK) Convertible Debt (2017 - 2025)

HealthLynked (HLYK) has disclosed Convertible Debt for 7 consecutive years, with $4.2 million as the latest value for Q3 2025.

  • On a quarterly basis, Convertible Debt rose 3253.11% to $4.2 million in Q3 2025 year-over-year; TTM through Sep 2025 was $4.2 million, a 3253.11% increase, with the full-year FY2024 number at $131615.0, up 165.26% from a year prior.
  • Convertible Debt was $4.2 million for Q3 2025 at HealthLynked, up from $50000.0 in the prior quarter.
  • In the past five years, Convertible Debt ranged from a high of $4.2 million in Q3 2025 to a low of $16428.0 in Q3 2023.
  • A 3-year average of $707437.0 and a median of $88158.0 in 2024 define the central range for Convertible Debt.
  • Biggest YoY gain for Convertible Debt was 3253.11% in 2025; the steepest drop was 95.0% in 2025.
  • HealthLynked's Convertible Debt stood at $49618.0 in 2023, then skyrocketed by 165.26% to $131615.0 in 2024, then surged by 3118.11% to $4.2 million in 2025.
  • Per Business Quant, the three most recent readings for HLYK's Convertible Debt are $4.2 million (Q3 2025), $50000.0 (Q2 2025), and $50000.0 (Q1 2025).